NF-KAPPAB1 DEFICIENCY WORSENS NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN MICE BY PROMOTING LYMPHOCYTE-MEDIATED RESPONSES

被引：0

作者：

Locatelli, I. ^{[1
]}

Sutti, S. ^{[1
]}

Vacchiano, M. ^{[1
]}

Bozzola, C. ^{[1
]}

Albano, E. ^{[1
]}

机构：

[1] Univ E Piedmont, Dept Med Sci, Novara, Italy

来源：

JOURNAL OF HEPATOLOGY | 2012年 / 56卷

关键词：

D O I：

10.1016/S0168-8278(12)61259-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1247

引用

页码：S493 / S494

页数：2

共 50 条

[31] Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?
Nelson, James E.
Roth, Christian L.
Wilson, Laura A.
Yates, Katherine P.
Aouizerat, Bradley
Morgan-Stevenson, Vicki
Whalen, Elizabeth
Hoofnagle, Andrew
Mason, Michael
Gersuk, Vivian
Yeh, Matthew M.
Kowdley, Kris V.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (06): : 852 - 863
[32] Role of Co-Stimulatory Signals Mediated by ICOS-ICOSL Dyad in the Evolution of Non-Alcoholic Steatohepatitis (NASH)
Sutti, S.
Ramavath, N. N.
Gadipudi, L. L.
Bozzola, C.
Clemente, N.
Gigliotti, L. C.
Boggio, E.
Novo, E.
Parola, M.
Dianzani, U.
Albano, E.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : S94 - S94
[33] Cromolyn Sodium Ameliorates Mast Cell(MC)-mediated Hepatic Damage in a Murine Model of Non-alcoholic Steatohepatitis (NASH)
Kundu, Debjyoti
Zhou, Tianhao
Kennedy, Lindsey
Kyritsi, Konstantina
Alpini, Gianfranco
Francis, Heather
AMERICAN JOURNAL OF PATHOLOGY, 2022, 192 (09): : S8 - S8
[34] Combinational applicaton of silybin and tangeretin attenuates the progression of non-alcoholic steatohepatitis (NASH) in mice via modulating lipid metabolism
Suguro, Rinkiko
Pang, Xiao-cong
Yuan, Zhong-wen
Chen, Si-yao
Zhu, Yi-Zhun
Xie, Ying
PHARMACOLOGICAL RESEARCH, 2020, 151
[35] Novel Rho associated coiled kinase inhibitor improves hepatic fibrosis in mice model of non-alcoholic steatohepatitis (NASH)
Ali, Quaisar
Prakash, Natalia
Dalapati, Sony
Li, Jingsong
Goldberg, Itzhak
Paka, Latha
JOURNAL OF HEPATOLOGY, 2020, 73 : S524 - S524
[36] PHASE 1 STUDY TO TEST SAFETY AND DOSE OF A CHOLECYSTOKININ RECEPTOR ANTAGONIST, PROGLUMIDE, IN NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Rabiee, Atoosa
Gay, Martha D.
Shivapurkar, Narayan
Cao, Hong
Nadella, Sandeep
Smith, Coleman
Lewis, James H.
Bansal, Sunil
Cheema, Amrita
Kwagyan, John
Smith, Jill P.
GASTROENTEROLOGY, 2022, 162 (07) : S1274 - S1274
[37] ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation
Zhang, Zechuan
Xu, Xiaoliang
Tian, Wenfang
Jiang, Runqiu
Lu, Yijun
Sun, Qikai
Fu, Rao
He, Qifeng
Wang, Jincheng
Liu, Yang
Yu, Hailong
Sun, Beicheng
JOURNAL OF HEPATOLOGY, 2020, 72 (05) : 976 - 989
[38] The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH)
Jia, Yue
Ji, Ping
French, Barbara
Tillman, Brittany
French, Samuel W.
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 108 : 156 - 163
[39] The lack of PPARα exacerbated the progression of non-alcoholic steatohepatitis in mice with spleen deficiency syndrome by triggering an inflammatory response
Huang, Jiawen
Li, Jiayu
Peng, Yuan
Cui, Tianqi
Guo, Jingyi
Duan, Siwei
Zhou, Kaili
Huang, Shangyi
Chen, Jiabing
Yi, Qincheng
Qiu, Min
Chen, Tingting
Wu, Xiaoqin
Ma, Chenlu
Zhang, Ziyi
Zheng, Yi
Tang, Xi
Pang, Yanqing
Zhang, Lei
Zhong, Chong
Gao, Yong
FRONTIERS IN IMMUNOLOGY, 2024, 15
[40] Toll-like receptor 5 signalling mediates pro-inflammatory and fibrogenic responses in non-alcoholic steatohepatitis (NASH)
Li, Wenhao
Garrido, Patricia
Mir, Iris Gines
Waller, Kathryn
Jong, Anja De
Brindley, James Hallimond
Khan, Waleed
Boot, James
Mein, Chaz
Loy, John
Devalia, Kalpana
Alazawi, William
GUT, 2023, 72 (SUPPL_2) : A12 - A12

← 1 2 3 4 5 →